Robert Ghenchev
Direktor/Vorstandsmitglied bei OXFORD BIOMEDICA PLC
Aktive Positionen von Robert Ghenchev
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OXFORD BIOMEDICA PLC | Direktor/Vorstandsmitglied | 24.06.2019 | - |
EXSCIENTIA PLC | Direktor/Vorstandsmitglied | 01.05.2020 | - |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Portfolio Manager-Aktien | 01.01.2021 | - | |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Private Equity Investor | 01.01.2018 | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 01.05.2020 | - |
Mission Bio, Inc.
Mission Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | - | - |
Mightyowl, Inc. | Direktor/Vorstandsmitglied | - | - |
Novo Holdings Equity Us, Inc. | Corporate Officer/Principal | - | - |
Quanta Dialysis Technologies, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Robert Ghenchev
Ehemalige bekannte Positionen von Robert Ghenchev
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░░ ░ ░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Robert Ghenchev
McGill University | Undergraduate Degree |
University of Oxford | Graduate Degree |
Statistik
International
Vereinigtes Königreich | 6 |
Vereinigte Staaten | 6 |
Dänemark | 3 |
Operativ
Director/Board Member | 8 |
Corporate Officer/Principal | 2 |
Portfolio Manager-Equities | 1 |
Sektoral
Finance | 4 |
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
Technology Services | |
EXSCIENTIA PLC | Health Technology |
Private Unternehmen | 8 |
---|---|
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Finance |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Finance |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Moelis & Co. (UK) LLP
Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Finance |
Mission Bio, Inc.
Mission Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA. | Commercial Services |
Mightyowl, Inc. | |
Novo Holdings Equity Us, Inc. | |
Quanta Dialysis Technologies, Inc. |
- Börse
- Insiders
- Robert Ghenchev
- Erfahrung